1. |
Siegel R, Ma J, Zou Z, <italic>et al</italic>. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
|
2. |
陈万青, 郑荣寿, 张思维, 等. 2012 年中国恶性肿瘤发病和死亡分析. 中国肿瘤, 2015, 24(1): 1-8.
|
3. |
Nasir BS, Bryant AS, Minnich DJ, <italic>et al</italic>. The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy. Ann Thorac Surg, 2014, 98(3): 1008-1012.
|
4. |
Donington JS, Pass HI. Surgical resection of non-small cell lung cancer with N2 disease. Thorac Surg Clin, 2014, 24(4): 449-456.
|
5. |
Darling GE, Allen MS, Decker PA, <italic>et al</italic>. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest, 2010, 139(5): 1124-1129.
|
6. |
Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978, 76(6): 832-839.
|
7. |
Vegar Zubović S, Kristić S, Hadžihasanović B. Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer. Med Glas (Zenica), 2017, 14(2): 199-203.
|
8. |
Kim AW. Lymph node drainage patterns and micrometastasis in lung cancer. Semin Thorac Cardiovasc Surg, 2009, 21(4): 298-308.
|
9. |
Detterbeck FC, Boffa DJ, Kim AW, <italic>et al</italic>. The eighth edition lung cancer stage classification. Chest, 2017, 151(1): 193-203.
|
10. |
Ettinger DS, Wood DE, Akerley W, <italic>et al</italic>. NCCN guidelines insights: non-small cell lung cancer, version 4. 2016. J Natl Compr Canc Netw, 2016, 14(3): 255-264.
|
11. |
Beigelman-Aubry C, Dunet V, Brun AL. CT imaging in pre-therapeutic assessment of lung cancer. Diagn Interv Imaging, 2016, 97(10): 973-989.
|
12. |
Bustos García de Castro A, Ferreirós Domínguez J, Delgado Bolton R, <italic>et al</italic>. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings. Radiologia, 2017, 59(2): 147-158.
|
13. |
Ahmad U, Crabtree TD, Patel AP, <italic>et al</italic>. Adjuvant chemotherapy is associated with improved survival in locally invasive node negative non-small cell lung cancer. Ann Thorac Surg, 2017, 104(1): 303-307.
|
14. |
Wang J, Liu F, Huang DX, <italic>et al</italic>. Post-operative treatment with cisplatin and vinorelbine in Chinese patients with non-small cell lung cancer: a clinical prospective analysis of 451 patients. Asian Pac J Cancer Prev, 2012, 13(9): 4505-4510.
|
15. |
Okada M, Nishio W, Sakamoto T, <italic>et al</italic>. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg, 2003, 126(2): 558-562.
|
16. |
Ramirez RA, Wang CG, Miller LE, <italic>et al</italic>. Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol, 2012, 30(23): 2823-2828.
|
17. |
Osarogiagbon RU, Hilsenbeck HL, Sales EW, <italic>et al</italic>. Improving the pathologic evaluation of lung cancer resection specimens. Transl Lung Cancer Res, 2015, 4(4): 432-437.
|
18. |
Watanabe S. Lymph node dissection for lung cancer: past, present, and future. Gen Thorac Cardiovasc Surg, 2014, 62(7): 407-414.
|
19. |
Tournoy KG, Maddens S, Gosselin R, <italic>et al</italic>. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax, 2007, 62(8): 696-701.
|
20. |
Shim SS, Lee KS, Kim BT, <italic>et al</italic>. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology, 2005, 236(3): 1011-1019.
|
21. |
Schreyögg J, Weller J, Stargardt T, <italic>et al</italic>. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer. J Nucl Med, 2010, 51(11): 1668-1675.
|
22. |
Park SY, Yoon JK, Park KJ, <italic>et al</italic>. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. Cancer Imaging, 2015, 15: 21.
|
23. |
Watanabe S, Oda M, Go T, <italic>et al</italic>. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg, 2001, 20(5): 1007-1011.
|
24. |
逄旭光, 蒋伟, 王群, 等. 早期非小细胞肺癌淋巴结清扫范围的探讨. 中国临床医学, 2012, 19(6): 616-618.
|
25. |
谢远才, 李运, 王俊, 等. 直径≤3 cm的周围型非小细胞肺癌纵淋巴结转移规律的初步研究. 中国微创外科志, 2010, 10(7): 577-580.
|
26. |
陈健, 许凝, 栗新燕. T1 期非小细胞肺癌清扫肺内淋巴结的临床意义. 中国胸心血管外科临床杂志, 2016, 23(4): 341-345.
|
27. |
Matsumura Y, Hishida T, Yoshida J, <italic>et al</italic>. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection. J Thorac Oncol, 2012, 7(11): 1691-1697.
|
28. |
马海波, 丁志丹, 曲戈, 等. 非小细胞肺癌隆突下淋巴结转移与临床病理特征的关系. 中国胸心血管外科临床杂志, 2013, 20(1): 70-73.
|
29. |
Liang W, He J, Shen Y, <italic>et al</italic>. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: A population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol, 2017, 35(11): 1162-1170.
|
30. |
张磊, 布仁吉雅, 王宇飞, 等. 非小细胞肺癌13 组、14 组淋巴结转移规律探讨. 中国肺癌杂志, 2017, 20(4): 248-252.
|
31. |
崔岳, 杨晓军, 谢天鹏, 等. 非小细胞肺癌肺内淋巴结转移规律的临床研究. 中国胸心血管外科临床杂志, 2016, 23(10): 982-987.
|
32. |
Zhang DG, Chen XC, Zhu DX, <italic>et al</italic>. Intrapulmonary lymph node metastasis is common in clinically staged ⅠA adenocarcinoma of the lung. Thoracic cancer, 2019, 10(2): 123-127.
|
33. |
Smeltzer MP, Faris N, Yu X, <italic>et al</italic>. Missed intrapulmonary lymph node metastasis and survival after resection of non-small cell lung cancer. Ann Thorac Surg, 2016, 102(2): 448-453.
|
34. |
Dai C, Shen J, Ren Y, <italic>et al</italic>. Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol, 2016, 34(26): 3175-3182.
|